{"id":64364,"date":"2025-02-06T00:01:16","date_gmt":"2025-02-06T00:01:16","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/02\/06\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/"},"modified":"2025-02-06T00:01:16","modified_gmt":"2025-02-06T00:01:16","slug":"argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/","title":{"rendered":"Argent BioPharma: A Hidden Gem traded Under $12M&#8211;Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment"},"content":{"rendered":"<div>\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">PERTH, Australia<\/span>, Feb. 6, 2025 \/PRNewswire\/ &#8212; <b>Argent BioPharma<\/b> (ASX: RGT) (OTCQB: RGTLF)<b>, a clinical-stage biopharmaceutical company brings hope to epilepsy patients.<\/b><\/span><\/p>\n<p>For thousands of patients with refractory epilepsy\u2014commonly referred to as drug-resistant epilepsy\u2014the search for effective treatment often feels like navigating an endless maze. These individuals, about 30% of the epilepsy community, live with seizures that persist despite conventional therapies. Now, a groundbreaking solution, CannEpil\u00ae, is offering hope.<\/p>\n<p>Developed by Argent BioPharma Limited, CannEpil\u00ae\u00a0is an oral mucosal solution with a high-CBD, low-THC formulation. It is designed to reduce seizure frequency and severity while minimizing psychoactive effects. After years of clinical development, CannEpil\u00ae\u00a0is making waves in the UK as part of a movement to transform severe epilepsy treatment.<\/p>\n<p>This breakthrough follows GW Pharmaceuticals&#8217; <span class=\"xn-money\">$7.2 billion<\/span> acquisition, highlighting the potential of cannabis-based epilepsy treatments. Argent BioPharma&#8217;s CannEpil\u00ae\u00a0is poised to follow a similar trajectory, offering a novel solution for drug-resistant epilepsy patients worldwide.<\/p>\n<p><b>A Milestone for UK Patients<\/b><\/p>\n<p>The journey of CannEpil\u00ae\u00a0in the UK has been historic. In collaboration with the I AM Billy Foundation\u2014named after <span class=\"xn-person\">Billy Caldwell<\/span>, a young boy whose severe epilepsy sparked a national conversation about medical cannabis\u2014the first UK patient has received CannEpil\u00ae\u00a0under the NHS&#8217;s Refractory Epilepsy Specialist Clinical Advisory Service (RESCAS).<\/p>\n<p>The inclusion of CannEpil\u00ae\u00a0in the UK&#8217;s Named Patient Request system is a game-changer. This pathway allows doctors on the General Medical Council (GMC) Specialist Register to prescribe it to patients with urgent medical needs. For families who have struggled for years, this development is a much-needed lifeline.<\/p>\n<p><b>What Makes CannEpil\u00ae\u00a0Stand Out?<\/b><\/p>\n<p>CannEpil\u00ae&#8217;s success lies in its rigorous clinical testing and safety profile. A notable Australian study confirmed it does not impair driving performance, offering reassurance to patients and families. Its rollout in <span class=\"xn-location\">Ireland<\/span> in 2019, under full governmental health insurance, marked the beginning of its international impact.<\/p>\n<p>Now, with availability in the UK, CannEpil\u00ae\u00a0is not just a treatment\u2014it is a symbol of progress in the fight against drug-resistant epilepsy. Its high-CBD content, known for its anti-seizure properties, provides an effective alternative for patients who have exhausted other options.<\/p>\n<p>Additionally, CannEpil\u00ae\u00a0has undergone rigorous clinical evaluation, with studies demonstrating a strong safety profile, including evidence that it does not impair activities such as driving. This focus on efficacy and safety sets CannEpil\u00ae\u00a0apart as a leading option for refractory epilepsy patients who have not responded to conventional treatments.<\/p>\n<p>Edison Report:<br \/><a href=\"https:\/\/argentbiopharma.com\/research_reports\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/argentbiopharma.com\/research_reports\/<\/a><\/p>\n<p><b>Argent\u00a0BioPharma<br \/><\/b><span class=\"xn-person\">Roby Zomer<\/span><br \/>CEO &amp; Managing Director<br \/>+61 8 6555 2950<br \/><a href=\"mailto:info@argentbiopharma.com\" target=\"_blank\" rel=\"nofollow\">info@argentbiopharma.com<\/a><\/p>\n<p><b>Argent BioPharma<br \/><\/b><span class=\"xn-person\">Rowan Harland<\/span><br \/>Company Secretary<br \/>+61 8 6555 2950<br \/><a href=\"mailto:info@argentbiopharma.co.uk\" target=\"_blank\" rel=\"nofollow\">info@argentbiopharma.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>PERTH, Australia, Feb. 6, 2025 \/PRNewswire\/ &#8212; Argent BioPharma (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company brings hope to epilepsy patients. For thousands of patients with refractory epilepsy\u2014commonly referred to as drug-resistant epilepsy\u2014the search for effective treatment often feels like navigating an endless maze. These individuals, about 30% of the epilepsy community, live with [&#8230;]\n","protected":false},"author":1,"featured_media":85254,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-64364","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Argent BioPharma: A Hidden Gem traded Under $12M-Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Argent BioPharma: A Hidden Gem traded Under $12M--Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment\" \/>\n<meta property=\"og:description\" content=\"PERTH, Australia, Feb. 6, 2025 \/PRNewswire\/ &#8212; Argent BioPharma (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company brings hope\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-06T00:01:16+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Argent BioPharma: A Hidden Gem traded Under $12M&#8211;Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment\",\"datePublished\":\"2025-02-06T00:01:16+00:00\",\"dateModified\":\"2025-02-06T00:01:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/\"},\"wordCount\":449,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/\",\"name\":\"Argent BioPharma: A Hidden Gem traded Under $12M-Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-02-06T00:01:16+00:00\",\"dateModified\":\"2025-02-06T00:01:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Argent BioPharma: A Hidden Gem traded Under $12M&#8211;Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Argent BioPharma: A Hidden Gem traded Under $12M-Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/","og_locale":"en_US","og_type":"article","og_title":"Argent BioPharma: A Hidden Gem traded Under $12M--Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment","og_description":"PERTH, Australia, Feb. 6, 2025 \/PRNewswire\/ &#8212; Argent BioPharma (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company brings hope","og_url":"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-02-06T00:01:16+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Argent BioPharma: A Hidden Gem traded Under $12M&#8211;Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment","datePublished":"2025-02-06T00:01:16+00:00","dateModified":"2025-02-06T00:01:16+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/"},"wordCount":449,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/","url":"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/","name":"Argent BioPharma: A Hidden Gem traded Under $12M-Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-02-06T00:01:16+00:00","dateModified":"2025-02-06T00:01:16+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report-assigned-a-327m-valuation-to-its-breakthrough-epilepsy-treatment-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Argent BioPharma: A Hidden Gem traded Under $12M&#8211;Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64364","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=64364"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64364\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/85254"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=64364"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=64364"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=64364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}